Merck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared Holz

June 7, 2023
Merck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared HolzMerck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared Holz

Jared Holz, Mizuho healthcare sector specialist, joins ‘Fast Money’ to discuss Merck’s lawsuit against the federal government over Medicare drug pricing.

Share This

Latest Mizuho News

See all news
Wall Street jumps to near one-month highs after US-Iran ceasefire

Wall Street jumps to near one-month highs after US-Iran ceasefire

April 8, 2026
OpenAI vs. Anthropic: the IPO battle that could define the future of AI investing

OpenAI vs. Anthropic: the IPO battle that could define the future of AI investing

April 1, 2026
Biopharma thesis starting to move away from obesity drugs, says Mizuho’s Jared Holz

Biopharma thesis starting to move away from obesity drugs, says Mizuho’s Jared Holz

March 20, 2026

Mizuho news from around the globe

 Mizuho Global News
back-to-top-blue